Europe Anti-Nuclear Antibody Test Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

February 2018 | 248 pages | ID: E4712F38699EN
Data Bridge Market Research

Abstracts

The Europe anti-nuclear antibody test market is expected to reach USD 491.05 million by 2025, from USD 268.98 million in 2017 growing at a CAGR of 7.9% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

The major factors driving the growth of this market are increasing incidence of autoimmune diseases, rising medical insurance, and rise in government healthcare protection.

The key market players for Europe anti-nuclear antibody test market are listed below:

• Bio-Rad Laboratories, Inc.
• Alere, Inc.
• Trinity Biotech
• Thermo Fisher Scientific Inc.
• Antibodies Inc.
• EUROIMMUN AG
• Immuno Concepts

The market is further segmented into:

• Product
• Test
• Disease
• End-user

The Europe anti-nuclear antibody test market is segmented on the basis of product into assay kits & reagents, systems, and software. In 2018, assay kits & reagents is expected to dominate the Europe anti-nuclear antibody test market with 59.2% market share and is expected to reach USD 294.67 million by 2025, with the highest CAGR of 8.1% in the forecast period 2018 to 2025.

The Europe anti-nuclear antibody test market is segmented on the basis of test into indirect immunofluorescence, ELISA, and multiplex testing. In 2018, indirect immunofluorescence is expected to dominate the Europe anti-nuclear antibody test market with 59.9% market share and is expected to reach USD 284.10 million by 2025, with the CAGR of 7.4% in the forecast period 2018 to 2025. However, multiplex testing market segment is expected to grow at the highest CAGR of 9.2% in the forecast period, and is expected to reach USD 82.42 million in 2025 from USD 41.21 million in 2017.

The Europe anti-nuclear antibody test market is segmented on the basis of disease into systemic lupus erythematosus, Sjögren’s syndrome, rheumatoid arthritis, scleroderma, polymyositis, and others. In 2018, systemic lupus erythematosus is expected to dominate the Europe anti-nuclear antibody test market with 51.3% market share and is expected to reach USD 256.05 million by 2025, with the highest CAGR of 8.2% in the forecast period 2018 to 2025.

The Europe anti-nuclear antibody test market is segmented on the basis of end-user into hospitals, clinics, physician office laboratories, and others. In 2018, hospitals is expected to dominate the Europe anti-nuclear antibody test market with 60.3% market share and is expected to reach USD 299.43 million by 2025, with the highest CAGR of 8.1% in the forecast period 2018 to 2025.

Based on geography, the Europe anti-nuclear antibody test market is segmented into geographical regions, such as,

• Germany,
• United Kingdom,
• France,
• Spain,
• Italy,
• Russia,
• Turkey,
• Belgium,
• Nether lands,
• Switzerland,
• Rest of Europe

Covered in this report

The report covers the present scenario and the growth prospects of the Europe anti-nuclear antibody test for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

Contents

1. INTRODUCTION

1.1. Objectives Of The Study
1.2. Market Definition
1.3. Overview Of Europe Anti-Nuclear Antibody Test Market
1.4. Currency And Pricing
1.5. Limitation
1.6. Markets Covered

2. MARKET SEGMENTATION

2.1. Markets Covered
2.2. Geographic Scope
2.3. Years Considered For The Study
2.4. Currency And Pricing
2.5. Research Methodology
2.6. Primary Interviews With Key Opinion Leaders
2.7. Secondary Sources
2.8. Assumptions

3. MARKET OVERVIEW

3.1. Drivers
  3.1.1. Increasing Incidence Of Autoimmune Diseases
  3.1.2. Rising Medical Insurance
  3.1.3. Rise In Government Healthcare Protection
3.2. Restraints
  3.2.1. Strict Regulation For Product Approval
3.3. Opportunities
  3.3.1. Increasing Growth In Healthcare Expenditure
  3.3.2. Emerging Markets
  3.3.3. Laboratory Automation Favors The Market
3.4. Challenges
  3.4.1. Lack Of Skilled Professionals

4. EXECUTIVE SUMMARY

5. PREMIUM INSIGHTS

6. EUROPE ANTI-NUCLEAR ANTIBODY TEST MARKET, BY PRODUCT

6.1. Overview
6.2. Assay Kits & Reagents
6.3. Systems
6.4. Software

7. EUROPE ANTI-NUCLEAR ANTIBODY TEST MARKET, BY TEST

7.1. Overview
7.2. Indirect Immunofluorescence
7.3. Elisa
7.4. Multiplex Testing

8. EUROPE ANTI-NUCLEAR ANTIBODY TEST MARKET, BY DISEASE

8.1. Overview
8.2. Rheumatoid Arthritis
8.3. Systemic Lupus Erythematosus
8.4. Sjögren’S Syndrome
8.5. Scleroderma
8.6. Polymyositis
8.7. Others

9. EUROPE ANTI-NUCLEAR ANTIBODY TEST MARKET, BY END USER

9.1. Overview
9.2. Hospitals
9.3. Clinics
9.4. Physician Office Laboratories
9.5. Others

10. EUROPE ANTI-NUCLEAR ANTIBODY TEST MARKET, BY GEOGRAPHY

10.1. Overview
10.2. Europe
  10.2.1. Germany
  10.2.2. France
  10.2.3. U.K.
  10.2.4. Italy
  10.2.5. Spain
  10.2.6. Switzerland
  10.2.7. Netherlands
  10.2.8. Belgium
  10.2.9. Russia
  10.2.10. Turkey
  10.2.11. Rest Of Europe

11. EUROPE ANTI-NUCLEAR ANTIBODY TEST MARKET,

Company Landscape
11.1. Company Share Analysis: Europe
11.2. Company Share Analysis: North America
11.3. Company Share Analysis: Europe
11.4. Company Share Analysis: Asia Pacific

12. COMPANY PROFILES

12.1. Thermo Fisher Scientific Inc.
  12.1.1. Company Overview
  12.1.2. Thermo Fisher Scientific Inc.:Revenue Analysis
  12.1.3. Product Portfolio
  12.1.4. Recent Developments
12.2. Merck Kgaa
  12.2.1. Company Overview
  12.2.2. Merck Kgaa: Revenue Analysis
  12.2.3. Product Portfolio
  12.2.4. Recent Developments
12.3. Alere Inc.
  12.3.1. Company Overview
  12.3.2. Alere Inc.: Revenue Analysis
  12.3.3. Product Portfolio
  12.3.4. Recent Developments
12.4. Trinity Biotech
  12.4.1. Company Overview
  12.4.2. Trinity Biotech: Company Overview
  12.4.3. Product Portfolio
  12.4.4. Recent Developments
12.5. Antibodies Inc.
  12.5.1. Company Overview
  12.5.2. Antibodies Inc.: Revenue Analysis
  12.5.3. Product Portfolio
  12.5.4. Recent Developments
12.6. Bio-Rad Laboratories, Inc.
  12.6.1. Company Overview
  12.6.2. Bio-Rad Laboratories, Inc.: Company Snapshot
  12.6.3. Product Portfolio
  12.6.4. Recent Developments
12.7. Euroimmun Ag (A Subsidiary Of Perkinelmer Inc.)
  12.7.1. Company Overview
  12.7.2. Perkinelmer Inc.: Revenue Analysis
  12.7.3. Product Portfolio
  12.7.4. Recent Developments
12.8. Immuno Concepts
  12.8.1. Company Overview
  12.8.2. Immuno Concepts: Company Snapshot
  12.8.3. Product Portfolio
  12.8.4. Recent Developments
12.9. Inova Diagnostics
  12.9.1. Company Overview
  12.9.2. Inova Diagnostics:Company Snapshot
  12.9.3. Product Portfolio
  12.9.4. Recent Developments
12.10. Zeus Scientific, Inc.
  12.10.1. Company Overview
  12.10.2. Zeus Scientific, Inc.: Company Snapshot
  12.10.3. Product Portfolio
  12.10.4. Recent Developments
12.11. Mbl International
  12.11.1. Company Overview
  12.11.2. Mbl International: Company Snapshot
  12.11.3. Product Portfolio
  12.11.4. Recent Developments
12.12. Medsource Ozone Biomedicals Pvt. Ltd
  12.12.1. Company Overview
  12.12.2. Medsource Ozone Biomedicals Pvt. Ltd: Company Snapshot
  12.12.3. Product Portfolio
  12.12.4. Recent Developments
12.13. Aesku Group Gmbh & Co. Kg
  12.13.1. Company Overview
  12.13.2. Aesku Group Gmbh & Co. Kg: Company Snapshot
  12.13.3. Product Portfolio
  12.13.4. Recent Developments

13. RELATED REPORTS

List Of Tables

LIST OF TABLES

Table 1 Europe Anti-Nuclear Antibody Test Market, By Product, 2016 - 2025 (Usd Million)
Table 2 Europe Assay Kits & Reagents Market, By Region, 2016 – 2025 (Usd Million)
Table 3 Europe Systems Market, By Region, 2016 – 2025 (Usd Million)
Table 4 Europe Softwares Market, By Region, 2016 – 2025 (Usd Million)
Table 5 Europe Anti-Nuclear Antibody Test Market, By Test, 2016 - 2025 (Usd Million)
Table 6 Europe Indirect Immunofluorescence Market, By Region, 2016 – 2025 (Usd Million)
Table 7 Europe Elisa Market, By Region, 2016 – 2025 (Usd Million)
Table 8 Europe Multiplex Testing Market, By Region, 2016 – 2025 (Usd Million)
Table 9 Europe Anti-Nuclear Antibody Test Market, By Disease, 2016 - 2025 (Usd Million)
Table 10 Europe Rheumatoid Arthritis Market, By Region, 2016 – 2025 (Usd Million)
Table 11 Europe Systemic Lupus Erythematosus Market, By Region, 2016 – 2025 (Usd Million)
Table 12 Europe Sjögren’S Syndrome Market, By Region, 2016 – 2025 (Usd Million)
Table 13 Europe Scleroderma Market, By Region, 2016 – 2025 (Usd Million)
Table 14 Europe Polymyositis Market, By Region, 2016 – 2025 (Usd Million)
Table 15 Europe Others Market, By Region, 2016 – 2025 (Usd Million)
Table 16 Europe Anti-Nuclear Antibody Test Market, By End User, 2016 - 2025 (Usd Million)
Table 17 Europe Hospitals Market, By Region, 2016 – 2025 (Usd Million)
Table 18 Europe Clinics Market, By Region, 2016 – 2025 (Usd Million)
Table 19 Europe Physician Office Laboratories Market, By Region, 2016 – 2025 (Usd Million)
Table 20 Europe Others Market, By Region, 2016 – 2025 (Usd Million)
Table 21 Europe Anti-Nuclear Antibody Test Market, By Region, 2016 – 2025 (Usd Million)
Table 22 Europe Anti-Nuclear Antibody Test Market, By Country, 2016-2025 (Usd Million)
Table 23 Europe Anti-Nuclear Antibody Test Market, By Product, 2016 - 2025 (Usd Million)
Table 24 Europe Anti-Nuclear Antibody Test Market, By Test, 2016 - 2025 (Usd Million)
Table 25 Europe Anti-Nuclear Antibody Test Market, By Disease, 2016 - 2025 (Usd Million)
Table 26 Europe Anti-Nuclear Antibody Test Market, By End User, 2016 - 2025 (Usd Million)
Table 27 Germany Anti-Nuclear Antibody Test Market, By Product, 2016 - 2025 (Usd Million)
Table 28 Germany Anti-Nuclear Antibody Test Market, By Test, 2016 - 2025 (Usd Million)
Table 29 Germany Anti-Nuclear Antibody Test Market, By Disease, 2016 - 2025 (Usd Million)
Table 30 Germany Anti-Nuclear Antibody Test Market, By End User, 2016 - 2025 (Usd Million)
Table 31 France Anti-Nuclear Antibody Test Market, By Product, 2016 - 2025 (Usd Million)
Table 32 France Anti-Nuclear Antibody Test Market, By Test, 2016 - 2025 (Usd Million)
Table 33 France Anti-Nuclear Antibody Test Market, By Disease, 2016 - 2025 (Usd Million)
Table 34 France Anti-Nuclear Antibody Test Market, By End User, 2016 - 2025 (Usd Million)
Table 35 U.K. Anti-Nuclear Antibody Test Market, By Product, 2016 - 2025 (Usd Million)
Table 36 U.K. Anti-Nuclear Antibody Test Market, By Test, 2016 - 2025 (Usd Million)
Table 37 U.K. Anti-Nuclear Antibody Test Market, By Disease, 2016 - 2025 (Usd Million)
Table 38 U.K. Anti-Nuclear Antibody Test Market, By End User, 2016 - 2025 (Usd Million)
Table 39 Italy Anti-Nuclear Antibody Test Market, By Product, 2016 - 2025 (Usd Million)
Table 40 Italy Anti-Nuclear Antibody Test Market, By Test, 2016 - 2025 (Usd Million)
Table 41 Italy Anti-Nuclear Antibody Test Market, By Disease, 2016 - 2025 (Usd Million)
Table 42 Italy Anti-Nuclear Antibody Test Market, By End User, 2016 - 2025 (Usd Million)
Table 43 Spain Anti-Nuclear Antibody Test Market, By Product, 2016 - 2025 (Usd Million)
Table 44 Spain Anti-Nuclear Antibody Test Market, By Test, 2016 - 2025 (Usd Million)
Table 45 Spain Anti-Nuclear Antibody Test Market, By Disease, 2016 - 2025 (Usd Million)
Table 46 Spain Anti-Nuclear Antibody Test Market, By End User, 2016 - 2025 (Usd Million)
Table 47 Switzerland Anti-Nuclear Antibody Test Market, By Product, 2016 - 2025 (Usd Million)
Table 48 Switzerland Anti-Nuclear Antibody Test Market, By Test, 2016 - 2025 (Usd Million)
Table 49 Switzerland Anti-Nuclear Antibody Test Market, By Disease, 2016 - 2025 (Usd Million)
Table 50 Switzerland Anti-Nuclear Antibody Test Market, By End User, 2016 - 2025 (Usd Million)
Table 51 Netherlands Anti-Nuclear Antibody Test Market, By Product, 2016 - 2025 (Usd Million)
Table 52 Netherlands Anti-Nuclear Antibody Test Market, By Test, 2016 - 2025 (Usd Million)
Table 53 Netherlands Anti-Nuclear Antibody Test Market, By Disease, 2016 - 2025 (Usd Million)
Table 54 Netherlands Anti-Nuclear Antibody Test Market, By End User, 2016 - 2025 (Usd Million)
Table 55 Belgium Anti-Nuclear Antibody Test Market, By Product, 2016 - 2025 (Usd Million)
Table 56 Belgium Anti-Nuclear Antibody Test Market, By Test, 2016 - 2025 (Usd Million)
Table 57 Belgium Anti-Nuclear Antibody Test Market, By Disease, 2016 - 2025 (Usd Million)
Table 58 Belgium Anti-Nuclear Antibody Test Market, By End User, 2016 - 2025 (Usd Million)
Table 59 Russia Anti-Nuclear Antibody Test Market, By Product, 2016 - 2025 (Usd Million)
Table 60 Russia Anti-Nuclear Antibody Test Market, By Test, 2016 - 2025 (Usd Million)
Table 61 Russia Anti-Nuclear Antibody Test Market, By Disease, 2016 - 2025 (Usd Million)
Table 62 Russia Anti-Nuclear Antibody Test Market, By End User, 2016 - 2025 (Usd Million)
Table 63 Turkey Anti-Nuclear Antibody Test Market, By Product, 2016 - 2025 (Usd Million)
Table 64 Turkey Anti-Nuclear Antibody Test Market, By Test, 2016 - 2025 (Usd Million)
Table 65 Turkey Anti-Nuclear Antibody Test Market, By Disease, 2016 - 2025 (Usd Million)
Table 66 Turkey Anti-Nuclear Antibody Test Market, By End User, 2016 - 2025 (Usd Million)
Table 67 Rest Of Europe Anti-Nuclear Antibody Test Market, By Product, 2016 - 2025 (Usd Million)

List Of Figures

LIST OF FIGURES

Figure 1 Europe Anti-Nuclear Antibody Test Market: Segmentation
Figure 2 Europe Anti-Nuclear Antibody Test Market: Data Triangulation
Figure 3 Europe Anti-Nuclear Antibody Test Market: Research Snapshot
Figure 4 Europe Anti-Nuclear Antibody Test Market: Bottom Up Approach
Figure 5 Europe Anti-Nuclear Antibody Test Market: Top Down Approach
Figure 6 Europe Anti-Nuclear Antibody Test Market:
Interview Demographics
Figure 7 Europe Anti-Nuclear Antibody Test Market: Segmentation
Figure 8 Europe Anti-Nuclear Antibody Test Market: By Product Type, 2017
Figure 9 Europe Anti-Nuclear Antibody Test Market: By Test, 2017
Figure 10 Europe Anti-Nuclear Antibody Test Market: By Disease, 2017
Figure 11 Europe Anti-Nuclear Antibody Test Market: By End User, 2017
Figure 12 Europe Anti-Nuclear Antibody Test Market Snapshot (2017)
Figure 13 Europe Anti-Nuclear Antibody Test Market: By Geography (2017)
Figure 14 Europe Anti-Nuclear Antibody Test Market: By Geography (2018)
Figure 15 Europe Anti-Nuclear Antibody Test Market: By Country (2017 & 2025)
Figure 16 Europe Anti-Nuclear Antibody Test Market:
By Product Type (2018 & 2025)
Figure 17 Europe Anti-Nuclear Antibody Test Market: Snapshot (2017)
Figure 18 Europe Anti-Nuclear Antibody Test Market: By Country (2017)
Figure 19 Europe Anti-Nuclear Antibody Test Market:
By Country (2018 & 2025)
Figure 20 Europe Anti-Nuclear Antibody Test Market, By Country (2017 & 2025)
Figure 21 Europe Anti-Nuclear Antibody Test Market, By Product (2018 & 2025)
Figure 22 Europe Anti-Nuclear Antibody Test Market: Company Share 2017 (%)